Roche is the recipient of the new approval, getting the go-ahead from the US regulator for its PATHWAY HER2 (4B5) test to ...

The new second-line indication was approved by the FDA in May, leading analysts at Jefferies to predict that it could add $500 million in worldwide peak sales for Enhertu and start to unlock ...

Transportation sector emissions have accelerated the climate crisis – automobiles are the second-largest source of greenhouse gases and have nearly doubled since 1990 – but they may soon be ...

Novartis issued stronger guidance than Wall Street expected. Elsewhere, Eisai and Biogen’s Alzheimer’s drug will get a closer ...

Analyst Insight: Planning for peak sales involves months of preparation inside and outside distribution centers and presents opportunities to boost revenue and capture new customers, particularly ...

Check out our top picks from Steam Next Fest October 2024 for an idea of what to expect when the next sale arrives. The best Steam feature for keeping track of sales is your wishlist. Browsing ...

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. East Asian Americans are ...

The week's most popular downloaded songs, ranked by sales data as compiled by Luminate. Tom MacDonald & Roseanne Barr New this week! Tom MacDonald Highest ranking debut Gains In Performance Week ...

THE WEEK'S TOP-SELLING ALBUMS ACROSS ALL GENRES, AS COMPILED BY LUMINATE. Mac Miller New this week! REMember Music/Warner Highest ranking debut Gains In Performance Week of February 1, 2025 click ...

This is a big win for Vertex, given that Journavx can potentially garner $4 billion in annual peak sales. For perspective, Vertex’s company-wide sales are around $11 billion currently.